These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36582903)

  • 1. Sustained ventricular arrhythmia and sinus node dysfunction revealing a cardiac amyloidosis: A case report.
    Machraa A; Ben Brahim W; Sidaty O; Fellat R; Fellat N
    Ann Med Surg (Lond); 2022 Dec; 84():104888. PubMed ID: 36582903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained Ventricular Tachycardia as a Harbinger of Cardiac Amyloidosis.
    Oladiran O; Oladunjoye A; Oladunjoye OO; Paudel A; Oke I; Motz L; Luber S; Licata A
    Am J Case Rep; 2020 Dec; 21():e927041. PubMed ID: 33281182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis.
    Ashraf I; Peck MM; Maram R; Mohamed A; Ochoa Crespo D; Kaur G; Malik BH
    Cureus; 2020 Aug; 12(8):e9842. PubMed ID: 32953349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of AL amyloidosis presenting with refractory ventricular fibrillation.
    Angsubhakorn N; Agdamag A; Sumransub N; Velangi P; Freund R; Martin CM; Alexy T
    Respir Med Case Rep; 2021; 32():101349. PubMed ID: 33552893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular Arrhythmias in Cardiac Amyloidosis: A Review of Current Literature.
    Khanna S; Lo P; Cho K; Subbiah R
    Clin Med Insights Cardiol; 2020; 14():1179546820963055. PubMed ID: 33088185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmia burden and implantable cardioverter-defibrillator outcomes in transthyretin cardiac amyloidosis.
    Brown MT; Yalamanchili S; Evans ST; Ram P; Blank EA; Lyle MA; Merchant FM; Bhatt KN
    Pacing Clin Electrophysiol; 2022 Apr; 45(4):443-451. PubMed ID: 35257420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis.
    Campanile A; Sozzi FB; Canetta C; Danzi GB
    Exp Clin Cardiol; 2013; 18(1):31-4. PubMed ID: 24294034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological Manifestations of Cardiac Amyloidosis:
    Hartnett J; Jaber W; Maurer M; Sperry B; Hanna M; Collier P; Patel DR; Wazni OM; Donnellan E
    JACC CardioOncol; 2021 Oct; 3(4):506-515. PubMed ID: 34729522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term survival of a patient with multiple myeloma-associated severe cardiac AL amyloidosis after implantation of a cardioverter-defibrillator].
    Mori M; Kitagawa T; Sasaki Y; Onaka T; Yonezawa A; Morimoto H; Haratake J; Imada K
    Rinsho Ketsueki; 2014 Apr; 55(4):450-5. PubMed ID: 24850457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmias in Cardiac Amyloidosis: Challenges in Risk Stratification and Treatment.
    Cheung CC; Roston TM; Andrade JG; Bennett MT; Davis MK
    Can J Cardiol; 2020 Mar; 36(3):416-423. PubMed ID: 32145868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.
    Patel KS; Hawkins PN; Whelan CJ; Gillmore JD
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25535224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.
    Kristen AV; Dengler TJ; Hegenbart U; Schonland SO; Goldschmidt H; Sack FU; Voss F; Becker R; Katus HA; Bauer A
    Heart Rhythm; 2008 Feb; 5(2):235-40. PubMed ID: 18242546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1309-19. PubMed ID: 11196552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillators in patients with cardiac amyloidosis.
    Lin G; Dispenzieri A; Kyle R; Grogan M; Brady PA
    J Cardiovasc Electrophysiol; 2013 Jul; 24(7):793-8. PubMed ID: 23489983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis.
    Hamon D; Algalarrondo V; Gandjbakhch E; Extramiana F; Marijon E; Elbaz N; Selhane D; Dubois-Rande JL; Teiger E; Plante-Bordeneuve V; Damy T; Lellouche N
    Int J Cardiol; 2016 Nov; 222():562-568. PubMed ID: 27513652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endomyocardial fibrosis presented by ventricular tachycardia: case report.
    Abdelnabi M; Almaghraby A; Saleh Y; Abd Elsamad S; Elfawal AS
    Egypt Heart J; 2019 Nov; 71(1):24. PubMed ID: 31745734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.
    Kim EJ; Holmes BB; Huang S; Lugo R; Al Aboud A; Goodman S; Hung RR; Slosky D; Stevenson WG; Michaud GF; John RM
    Europace; 2020 Aug; 22(8):1216-1223. PubMed ID: 32514579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
    Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
    Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis.
    Rehorn MR; Loungani RS; Black-Maier E; Coniglio AC; Karra R; Pokorney SD; Khouri MG
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1144-1154. PubMed ID: 32972550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.